DEO vs RNAC · P/E 16, $55.86B cap vs P/E 2.1, rev $38.9M
Diageo PLC ADR (DEO) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
DEO does not have a complete income-statement cache yet.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the DEO and RNAC stock pages for the full models.
Not investment advice.